MAPT and early-onset autosomal dominant Alzheimer disease: We decided to study the aggregation capacity of the Full Tau isoform, as this is a crucial aspect in the research of neurodegenerative diseases such as Alzheimer’s disease (AD) and other tauopathies [5,38].